An Open-Label Study With Extension Phase to Evaluate the Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Subjects (Age 1 Month to Less Than 18 Years) With Childhood Epilepsy

Eisai Clinical Trials

Protocol # E2007-G000-236

Study Overview

Study Compound: E2007

Drug Name: perampanel

Registry #: NCT04015141, 2023-507794-17, 2018-004456-38

Trial Period: May 2019 -

Indication: Epilepsy

Primary Endpoint: 1. Proportion of 50% Responders For All Seizures During the Maintenance Period of Core Study [Time Frame: Week 10 to Week 23]

Population
Males and females 1 Month to 18 Years (Child, Adult)
Study Status
Ongoing
Study Phase
Phase 2
Countries
Belgium, Czechia, France, Germany, Spain, United States See moreSee less

Clinical Trial Documents

Clinical Study Report Synopsis

No download available

Plain Language Protocol Synopsis (PLPS)

Download PDF

Plain Language Summary of Results (PLS)

No download available

Publication reference citation

Data Sharing

ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.

CSDR Sharing is not available for this study.

CSDR	Availability
Clinical Trial Data

Redacted documents may be available upon request for this study.

Document type	Availability
Protocol
SAP
Sample CRF
Full CSR